Skip to main content
. 2000 Mar 21;97(7):3631–3636. doi: 10.1073/pnas.050586497

Figure 5.

Figure 5

Status epilepticus (SE) does not alter GluR2 immunolabeling in DG granule cells. Same presentation as in Figs. 3 and 4. GluR2 immunoreactivity was unchanged 22 h after KA administration (B) when compared with control sections (A). GluR1 immunoreactivity also was unchanged after status epilepticus (C and D). (E and F) Superposition of images of GluR1 and GluR2 labeling show colocalization. iml, inner molecular layer; gcl, granule cell layer; h, hilus. (Scale bar: 50 μm.)